| niacin extended-release formulation / Generic mfg. |
NCT00046267: Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients |
|
|
| Completed | N/A | 30 | US | Niacin | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections, Hypercholesterolemia, Hypertriglyceridemia, Diabetes Mellitus | 12/06 | | | |
| Completed | N/A | 19 | Canada | Atorvastatin; Fenofibrate; Niacin, Lipotor; Tricor; Niaspan | McGill University Health Centre/Research Institute of the McGill University Health Centre | Coronary Arteriosclerosis, Hypoalphalipoproteinemias, Genetic Diseases, Inborn | 09/07 | 09/07 | | |
NCT01216956: Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed Dyslipidemia |
|
|
| Completed | N/A | 24 | Europe | Extended-release nicotinic acid versus placebo | Centre de Recherche en Nutrition Humaine Rhone-Alpe, Institut National de la Santé Et de la Recherche Médicale, France, GlaxoSmithKline | Insulin Sensitivity, Lipoproteins Metabolism, Non Esterified Fatty Acid Kinetics, Lipid Profile | 06/09 | 03/10 | | |
NCT00986986: Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels |
|
|
| Completed | N/A | 20 | US | extended release niacin, Niaspan | University of Hawaii, United States Department of Defense | HIV Infections, Dyslipidemia, Endothelial Dysfunction | 04/10 | 04/10 | | |
